{"id":"https://openalex.org/W18160508","doi":"https://doi.org/10.3928/1542-8877-19880801-10","title":"Aphakic Cystoid Macular Edema Secondary to Betaxolol Therapy","display_name":"Aphakic Cystoid Macular Edema Secondary to Betaxolol Therapy","publication_year":1988,"publication_date":"1988-08-01","ids":{"openalex":"https://openalex.org/W18160508","doi":"https://doi.org/10.3928/1542-8877-19880801-10","mag":"18160508","pmid":"https://pubmed.ncbi.nlm.nih.gov/2902544"},"language":"en","primary_location":{"id":"doi:10.3928/1542-8877-19880801-10","doi":"https://doi.org/10.3928/1542-8877-19880801-10","is_oa":false,"landing_page_url":"https://doi.org/10.3928/1542-8877-19880801-10","pdf_url":null,"source":{"id":"https://openalex.org/S4210179932","display_name":"Ophthalmic surgery, lasers & imaging retina","issn_l":"1542-8877","issn":["1542-8877","1938-2375","2325-8160","2325-8179"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ophthalmic Surgery, Lasers and Imaging Retina","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110096990","display_name":"Richard J. Hesse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1336053918","display_name":"Ochsner Health System","ror":"https://ror.org/003ngne20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336053918"]},{"id":"https://openalex.org/I2799767083","display_name":"Ochsner Medical Center","ror":"https://ror.org/0290qyp66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336053918","https://openalex.org/I2799767083"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard J Hesse","raw_affiliation_strings":["","Department of Ophthalmology, Ochsner Clinic, New Orleans, Louisiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]},{"raw_affiliation_string":"Department of Ophthalmology, Ochsner Clinic, New Orleans, Louisiana","institution_ids":["https://openalex.org/I1336053918","https://openalex.org/I2799767083"]}]},{"author_position":"last","author":{"id":null,"display_name":"John L Swan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John L Swan","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.00136178,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"19","issue":"8","first_page":"562","last_page":"564"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.04280000180006027,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cystoid-macular-edema","display_name":"cystoid macular edema","score":0.925000011920929},{"id":"https://openalex.org/keywords/betaxolol","display_name":"betaxolol","score":0.9610000252723694},{"id":"https://openalex.org/keywords/aphakia","display_name":"aphakia","score":0.7919999957084656},{"id":"https://openalex.org/keywords/beta-adrenergic-receptor-blockers","display_name":"beta-adrenergic receptor blockers","score":0.7900000214576721},{"id":"https://openalex.org/keywords/glaucoma-treatment","display_name":"glaucoma treatment","score":0.7480000257492065},{"id":"https://openalex.org/keywords/timolol","display_name":"timolol","score":0.7839999794960022},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6129999756813049}],"concepts":[{"id":"https://openalex.org/C2779938033","wikidata":"https://www.wikidata.org/wiki/Q794162","display_name":"Betaxolol","level":4,"score":0.9637152552604675},{"id":"https://openalex.org/C2778073030","wikidata":"https://www.wikidata.org/wiki/Q413994","display_name":"Timolol","level":3,"score":0.8206613063812256},{"id":"https://openalex.org/C2780347916","wikidata":"https://www.wikidata.org/wiki/Q1813737","display_name":"Macular edema","level":3,"score":0.7336221933364868},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.724474310874939},{"id":"https://openalex.org/C2778527774","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Glaucoma","level":2,"score":0.6014875173568726},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.5747360587120056},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.5616233944892883},{"id":"https://openalex.org/C40465926","wikidata":"https://www.wikidata.org/wiki/Q410568","display_name":"Adrenergic receptor","level":3,"score":0.4657156467437744},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.45648619532585144},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22093787789344788},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1533125638961792},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.11159968376159668}],"mesh":[{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002387","descriptor_name":"Cataract Extraction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005902","descriptor_name":"Glaucoma, Open-Angle","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008269","descriptor_name":"Macular Edema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D011183","descriptor_name":"Postoperative Complications","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011412","descriptor_name":"Propanolamines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011412","descriptor_name":"Propanolamines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015784","descriptor_name":"Betaxolol","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3928/1542-8877-19880801-10","doi":"https://doi.org/10.3928/1542-8877-19880801-10","is_oa":false,"landing_page_url":"https://doi.org/10.3928/1542-8877-19880801-10","pdf_url":null,"source":{"id":"https://openalex.org/S4210179932","display_name":"Ophthalmic surgery, lasers & imaging retina","issn_l":"1542-8877","issn":["1542-8877","1938-2375","2325-8160","2325-8179"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ophthalmic Surgery, Lasers and Imaging Retina","raw_type":"journal-article"},{"id":"pmid:2902544","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2902544","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ophthalmic surgery","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W12444146","https://openalex.org/W1998106074","https://openalex.org/W2070885841","https://openalex.org/W2088665553","https://openalex.org/W4250379532"],"related_works":["https://openalex.org/W2406006219","https://openalex.org/W1969342104","https://openalex.org/W2102879351","https://openalex.org/W2079180771","https://openalex.org/W1974846098","https://openalex.org/W2092822107","https://openalex.org/W2087247296","https://openalex.org/W2008096856","https://openalex.org/W4248095941","https://openalex.org/W4205341658"],"abstract_inverted_index":{"Since":[0],"the":[1,6,24],"approval":[2],"of":[3,8,26,40,75],"timolol":[4],"for":[5,28],"treatment":[7,25],"open-angle":[9],"glaucoma,":[10],"beta-adrenergic":[11,49,62],"blocking":[12],"drugs":[13],"have":[14,36],"replaced":[15],"epinephrine,":[16],"a":[17,47,60,73,92],"pure":[18],"alpha":[19],"and":[20,89],"beta":[21,68],"agonist,":[22],"as":[23],"choice":[27],"glaucoma":[29],"in":[30],"aphakic":[31],"patients.":[32],"To":[33],"date,":[34],"there":[35],"been":[37],"no":[38],"reports":[39],"cystoid":[41,78],"macular":[42,79],"edema":[43,80],"secondary":[44,81],"to":[45,82],"timolol,":[46],"non-selective":[48],"blocker":[50,64],"that":[51,65,85],"apparently":[52],"has":[53],"little":[54],"intrinsic":[55],"sympathomimetic":[56],"activity.":[57],"Betaxolol":[58],"is":[59],"new":[61],"receptor":[63],"preferentially":[66],"blocks":[67],"1":[69],"receptors.":[70],"We":[71],"report":[72],"case":[74],"angiographically":[76],"proven":[77],"betaxolol":[83],"therapy":[84],"resolved":[86],"after":[87,91],"discontinuation":[88],"recurred":[90],"monocular":[93],"therapeutic":[94],"trial.":[95]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}